Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial

Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s revision label in the footer has been updated to v3.6.4, signaling a behind-the-scenes release update without changes to the displayed study details.
    Difference
    0.1%
    Check dated 2026-07-25T15:51:57.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, representing a minor platform update to the page rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-07-04T04:26:55.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision tag on the page footer was updated from v3.6.0 to v3.6.2, reflecting a minor site maintenance update. The content and study details shown on the page remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-27T03:07:10.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study details page adds new user guidance sections and standardizes the Intervention/Treatment header; it also marks recruitment as no longer recruiting and updates the revision to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T15:37:45.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The page revision stamp was updated from v3.5.4 to v3.5.5, representing a minor version update.
    Difference
    0.1%
    Check dated 2026-06-05T09:58:46.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating a minor release. It reflects a maintenance update rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T04:29:31.000Z thumbnail image

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.